Dr. Jervis holds a Ph.D. in Protein Biochemistry and BSc (Hons) in Biology from the University of Glasgow and an M.B.A. from the University of Edinburgh, with a thesis in market research for biopharmaceutical manufacturing. Dr. Jervis’ role at Viragen is to develop, maintain, and protect the core technologies in the Company and is responsible for the development of the Company’s growing Intellectual Property portfolio and is named inventor on several patent applications. Dr. Jervis is responsible for part-directing the research and development of Viragen’s oncological and transgenic programs and the research teams within Viragen, including acting as liaison for Viragen’s global partners. Dr. Jervis was named one of Scotland’s top 50 Businesswomen in 2001.
|